09:24 AM EST, 03/07/2024 (MT Newswires) -- Catriona Yale, Chief Development Officer, on March 04, 2024, sold 20,646 shares in Akero Therapeutics ( AKRO ) for $732,727. Following the Form 4 filing with the SEC, Yale has control over a total of 78,415 shares of the company, with 78,415 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1744659/000095017024027509/xslF345X03/ownership.xml

Price: 29.93, Change: -0.07, Percent Change: -0.25